The West Coast innovation section got the chance to really prove its tech cred by going virtual Thursday (November 5) for the annual Technology Impact Awards (TIA). Top honours went to tech companies specializing in everything from reimagining the way labour markets are researched to the way agricultural economics work in the near future. The B.C. Tech Association’s annual showcase…
Read More
The authors broaden the understanding of the post-translational regulation of Capicua (CIC), which has now been implicated as a tumour suppressor in multiple cancer types, including glioma. In fact, CIC has been shown to mediate EGFR signalling as well as metastatic behaviour. They also delve into non-canonical CIC regulatory pathways and identify a novel E3-ligase, TRIM25, which can regulate CIC function at a post-translational level.
Read More
A Burnaby biotech company has enrolled and dosed its first volunteer with an oral DNA vaccine to prevent COVID-19. On Wednesday, Symvivo Corporation reported that “investigators have enrolled and dosed the first healthy volunteer in its bacTRL-Spike COVID-19 Phase I clinical trial in Australia.” According to the firm, the treatment delivers genetic material to the gut, which directs the body…
Read More
Fresh water is unequivocally one of British Columbia (BC)’s most valuable natural resources and is directly and indirectly tied to the health and wellbeing of British Columbians in immeasurable ways. Monitoring changes in freshwater ecosystems is vital to inform sound decision making by government managers as pressures on this resource intensify. A relatively simple way to measure these changes is…
Read More
Congratulations to the BC Children’s and BC Women’s investigators who were awarded funding through the Canadian Institutes of Health Research (CIHR) Project Grant Spring 2020 competition. Our research community received over $4 million in new research grants. Many of the investigators who were successful in this competition benefited from the expertise of Dr. Dawn McArthur, Director, Research & Technology Development…
Read More
Dr. Allison Eddy was named a Fellow by the Canadian Academy of Health Sciences (CAHS) on Sept. 18, 2020. She calls being selected a great honour. “Brainstorming with CAHS academic colleagues with diverse backgrounds and expertise will be an exciting opportunity. I am grateful for the incredible leadership opportunities that I have had in my current positions as chief of Pediatric Medicine at BC…
Read More
Dr. Thalia Field has been named to Canada’s Top 40 Under 40 list for 2020, an annual recognition of the exceptional achievements of 40 outstanding Canadians under the age of 40. Dr. Field, an associate professor in the department of medicine, is a stroke neurologist and clinician-researcher with a focus on clinical trials. She is currently leading a national study…
Read More
Alpha-9 Theranostics Inc.TM, a radiopharmaceutical company developing unique technology for imaging and treatment of metastatic cancer, today announced the completion of a Phase I/II clinical trial of its neuroendocrine tumour imaging agent A9T-1101 at BC Cancer, one of Canada’s premier cancer research and treatment centres. The outcome of the trial confirmed the utility, biodistribution and safety of A9T-1101.  Alpha-9 now…
Read More
The best and brightest of British Columbia’s emerging life sciences sector will be on display next week, as investors from around the world gather virtually to hear their pitches. The two-day event, organized by non-profit LifeSciences BC, will feature 33 up-and-coming companies, with up to 70 investors dialing in from Asia, Europe and the U.S. While the summit is an…
Read More